A PAM of mGlu4 has been demonstrated to activate noncanonical mGluR4 signaling in dendritic cells (DC) and induce a tolerogenic functional phenotype through IDO1, an immunoregulator and reduce neuroinflammation in a murine model of multiple sclerosis (Volpi et al., 2016). This evidence concerns the gene GRM4 and multiple sclerosis.